Argosy Healthcare Promotes Greg Mayer to Partner
Search

Argosy Healthcare Promotes Greg Mayer to Partner

Argosy Healthcare makes majority control investments, in partnership with founders and management teams, in healthcare companies that have from $1 million to $3 million of EBITDA

Argosy Healthcare Partners (AHP), a private equity firm focused exclusively on the healthcare sector, has promoted Greg Mayer to Partner. Mr. Mayer joined AHP in January 2022 to establish and lead the firm’s portfolio support group.

Before joining AHP, Mr. Mayer was the Director of Corporate Strategy and M&A at Avantor, a Pennsylvania-headquartered Fortune 500 life sciences tools and bioprocessing company. Before Avantor, he was an Associate covering healthcare in the high yield credit research group at Bank of America.

“We are very excited to recognize Greg’s contributions to AHP and announce his promotion to Partner,” said Paul Barrett, the managing partner of Argosy Healthcare. “Greg leads our portfolio support group and has done an outstanding job designing, building, and executing his program. Greg is a highly strategic, servant leader that does whatever it takes to support our partner companies and executive teams. We congratulate Greg on this earned promotion and are very excited for all that he and our group will accomplish together in the years ahead.”

Earlier in his career, Mr. Mayer spent six years as an Armor Officer in the United States Marine Corps. He has his undergraduate degree from the University of Maryland and his MBA from the University of North Carolina.

Argosy Capital formed Argosy Healthcare Partners in January 2021 and hired Mr. Barrett to lead the new investment strategy. Today, AHP makes majority control investments, in partnership with founders and management teams, in healthcare companies that have from $1 million to $3 million of EBITDA.

Argosy Capital makes control investments of $5 million to $25 million in niche manufacturing and business-to-business service companies with $20 million to $100 million of revenue and $3 million to $10 million of EBITDA. In July 2022, Argosy held a final and above-target closing of Argosy Investment Partners VI LP with $422 million in capital.

© 2025 Private Equity Professional | January 16, 2025

To search in site, type your keyword and hit enter